MedWatch

GN Hearing wants an EBITA margin of over 20 percent in 2024

At the hearing aid manufacturer’s Meet the Management day, CEO Gitte Aabo reports that the goal is reach the company’s previous earnings margin.

Photo: GN Store Nord / PR

Hearing aid manufacturer GN Hearing is not satisfied with its current earnings margin, which has taken some blows from the Covid-19 pandemic, said CEO at GN Hearing Gitte Aabo at the company’s Meet the Management day on Wednesday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs